Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
SYNLAB International GmbH is a premier European leader in clinical laboratory services and medical diagnostics. Headquartered in Germany, SYNLAB offers an extensive portfolio of over 5,000 routine and specialized diagnostic tests across more than 30 countries. The company serves patients, practicing doctors, clinics, hospitals, and other healthcare providers, as well as corporate clients and the pharmaceutical industry. SYNLAB is committed to delivering accurate and timely results, driving medical innovation, and improving patient outcomes through its vast network of laboratories and advanced diagnostic capabilities.
Serves as the central hub for global strategic management, corporate governance, finance, human resources, IT, and overall operational oversight for SYNLAB's international network of laboratories.
Modern office facilities designed to support a collaborative and efficient work environment, equipped with advanced communication technology to connect with global operations. The focus is on functional efficiency for a global headquarters.
The HQ work culture is characterized by professionalism, a strong focus on scientific excellence and innovation in diagnostics, and international collaboration. Employees often work in cross-functional teams to support the diverse needs of the global organization.
Munich's central European location, strong infrastructure, and access to a skilled talent pool make it an ideal base for managing SYNLAB's extensive European and international operations. It's the nerve center for strategic decisions and group-wide initiatives.
SYNLAB supports a wide range of functions globally, primarily focused on providing comprehensive medical laboratory services. This includes routine and specialized diagnostic testing, pathology services, veterinary diagnostics, environmental testing, and services for pharmaceutical clinical trials. Operations are supported by local and regional management, customer service, logistics, IT infrastructure, and quality assurance teams across its network in over 30 countries, predominantly in Europe, but also with a presence in Latin America, Africa, and the Middle East.
Moosacher Strasse 88
Munich
Bavaria
Germany
Address: Synlab House, Fort Parkway, Birmingham, B24 9FL, United Kingdom
To deliver localized diagnostic solutions, ensure compliance with national healthcare regulations (e.g., NHS standards), and expand SYNLAB's market presence in the UK and Irish healthcare markets.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, SYNLAB International GmbH' leadership includes:
SYNLAB International GmbH has been backed by several prominent investors over the years, including:
Over the past year, SYNLAB has seen key executive appointments, including a new Chief People Officer and an interim Chief Operating Officer, alongside a departure from the COO role. These changes support the company's ongoing strategic initiatives and operational focus.
Discover the tools SYNLAB International GmbH uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
SYNLAB commonly uses the firstname.lastname@synlab.com email format. While variations might exist for specific regions or roles, this is the most prevalent structure for corporate communications.
firstname.lastname@synlab.com
Format
jane.doe@synlab.com
Example
85%
Success rate
Cinven • April 24, 2024
Private equity firm Cinven announced the successful completion of its voluntary public takeover offer for SYNLAB AG. Cinven, which was already a major shareholder, secured over 80% of SYNLAB shares. This development marks a significant step towards a potential delisting and a new phase of private ownership, enabling focused strategic development for the diagnostics company....more
SYNLAB Group • February 29, 2024
SYNLAB announced its full-year 2023 financial results, reporting revenues of €2.64 billion. The company highlighted its resilience in a post-pandemic market and outlined its strategic priorities and financial outlook for 2024, focusing on organic growth and operational efficiency....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including SYNLAB International GmbH, are just a search away.